Julie Xing
Director/Board Member chez APTARGROUP, INC.
Fortune : 227 778 $ au 31/03/2024
Profil
Julie Xing is currently the Executive Chairman at Mundipharma (China) Pharmaceutical Co., Ltd.
and an Independent Director at AptarGroup, Inc. She previously worked at Eli Lilly & Co. as the Senior Director-Global New Product Planning from 2010 to 2019.
Julie also held positions at Panomics LLC as the VP, GM-Asia Pacific & Japan Operations, and at Envista Holdings Corp.
as the Global Senior VP & President-Greater China.
She holds a doctorate degree from The Hong Kong University of Science & Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
APTARGROUP, INC.
0,00% | 08/03/2024 | 1 583 ( 0,00% ) | 227 778 $ | 31/03/2024 |
Postes actifs de Julie Xing
| Sociétés | Poste | Début |
|---|---|---|
| APTARGROUP, INC. | Director/Board Member | 01/03/2023 |
Mundipharma (China) Pharmaceutical Co., Ltd.
 Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Beijing, China. | Chairman | 01/03/2023 |
Anciens postes connus de Julie Xing
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2019 |
Panomics LLC
 Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
| ENVISTA HOLDINGS CORPORATION | Corporate Officer/Principal | - |
Formation de Julie Xing
| The Hong Kong University of Science & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| APTARGROUP, INC. | Process Industries |
| ELI LILLY AND COMPANY | Health Technology |
| ENVISTA HOLDINGS CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Commercial Services |
Mundipharma (China) Pharmaceutical Co., Ltd.
Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Beijing, China. | Health Technology |
